BRCA1 is a cell cycle-regulated nuclear phosphoprotein.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1997-07-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.94.14.7138PMID 9207057PMCID PMC23770
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11b.

  1997cited by this paper
• Localization of BRCA1 and a splice variant identifies the nuclear localization signal

  1997cited by this paper
• Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-Δ11b

  1997cited by this paper
• Association of BRCA1 with Rad51 in mitotic and meiotic cells.

  1997cited by this paper
• Growth retardation and tumour inhibition by BRCA1

  1996cited by this paper
• Induction of apoptosis by the tumor suppressor protein BRCA1.

  1996cited by this paper
• Response: Location of BRCA1 in Human Breast and Ovarian Cancer Cells

  1996cited by this paper
• Transcriptional activation by BRCA1

  1996cited by this paper
• BRCA1 protein products: Antibody specificity…

  1996cited by this paper
• Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins.

  1996cited by this paper
• The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse.

  1996cited by this paper
• Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer.

  1996cited by this paper
• BRCA1 protein level is not affected by peptide growth factors in MCF10A cell line.

  1996cited by this paper
• Subcellular Localization and Analysis of Apparent 180-kDa and 220-kDa Proteins of the Breast Cancer Susceptibility Gene, BRCA1*

  1996cited by this paper
• Identification of a RING protein that can interact in vivo with the BRCA1 gene product

  1996cited by this paper
• Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development.

  1996cited by this paper
• BRCA1 mutations in a population-based sample of young women with breast cancer.

  1996cited by this paper
• Evidence for a transcriptional activation function of BRCA1 C-terminal region.

  1996cited by this paper
• Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities

  1996cited by this paper
• BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner.

  1996cited by this paper
• Antisense RNA to the putative tumor suppressor gene BRCA1 transforms mouse fibroblasts.

  1996cited by this paper
• Location of BRCA1 in Human Breast and Ovarian Cancer Cells

  1996cited by this paper
• The Nuclear Localization Sequences of the BRCA1 Protein Interact with the Importin-α Subunit of the Nuclear Transport Signal Receptor*

  1996cited by this paper
• BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells.

  1996cited by this paper
• Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells.

  1996cited by this paper
• BRCA1 is secreted and exhibits properties of a granin

  1996cited by this paper
• The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses

  1996cited by this paper
• Reply to “…and secreted tumour suppressors”

  1996cited by this paper
• The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues

  1995cited by this paper
• Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice.

  1995cited by this paper
• A human BRCA1 gene knockout

  1995cited by this paper
• Aberrant Subcellular Localization of BRCA1 in Breast Cancer

  1995cited by this paper
• Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression

  1995cited by this paper
• Cloning of an SNF2/SWI2-related Protein That Binds Specifically to the SPH Motifs of the SV40 Enhancer and to the HIV-1 Promoter (*)

  1995cited by this paper
• Somatic mutations in the BRCA1 gene in sporadic ovarian tumours

  1995cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• BRCA1 mutations in primary breast and ovarian carcinomas.

  1994cited by this paper
• Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer

  1994cited by this paper
• Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

  1993cited by this paper
• Molecular Cloning and Characterization of a Novel Rel/NF-χB Family Member Displaying Structural and Functional Homology to NF-χB p50/p105

  1992cited by this paper
• Molecular cloning and characterization of a novel Rel/NF-kappa B family member displaying structural and functional homology to NF-kappa B p50/p105.

  1992cited by this paper
• A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells.

  1991cited by this paper
• Solubilization of the receptor for the neuropeptide gastrin-releasing peptide (bombesin) with functional ligand binding properties.

  1990cited by this paper
• Linkage of early-onset familial breast cancer to chromosome 17q21.

  1990cited by this paper
• [38] Assay of corticotropin releasing factor

  1983cited by this paper
• Assay of corticotropin releasing factor.

  1983cited by this paper
• DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.

  1979cited by this paper
• Synchronization of mouse 3T3 and SV40 3T3 cells by way of centrifugal elutriation.

  1977cited by this paper

• The deubiquitinating enzyme Cezanne stabilizes BRCA1 by counteracting APC/C and Ube2S-dependent Lys11-linked ubiquitination

  2025cites this paper
• CITK modulates BRCA1 recruitment at DNA double strand breaks sites through HDAC6

  2025cites this paper
• miRNA-dependent resistance mechanisms to anti-hormonal therapies in estrogen receptor-positive breast cancer patients

  2025cites this paper
• EWS::FLI1 expression in human embryonic mesenchymal stem cells leads to transcriptional reprograming, defective DNA damage repair and Ewing sarcoma

  2025cites this paper
• Finding novel vulnerabilities of hypomorphic BRCA1 alleles

  2024cites this paper
• EXO1 protects BRCA1-deficient cells against toxic DNA lesions.

  2024cites this paper
• The role of RNF138 in DNA end resection is regulated by ubiquitylation and CDK phosphorylation

  2024cites this paper
• EXO1-mediated DNA repair by single-strand annealing is essential for BRCA1-deficient cells

  2023cites this paper
• BRCA1 and DNA damage response

  2022cites this paper
• BRCA1 deficiency in triple-negative breast cancer: Protein stability as a basis for therapy.

  2022cites this paper
• BRCA1 binds TERRA RNA and suppresses R-Loop-based telomeric DNA damage

  2021cites this paper
• The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer.

  2021cites this paper
• DNA double-strand break repair: Putting zinc fingers on the sore spot.

  2020cites this paper
• BRCA1/BARD1-dependent ubiquitination of NF2 regulates Hippo-YAP1 signaling

  2019cites this paper
• Proteome and phosphoproteome reveal mechanisms of action of atorvastatin against esophageal squamous cell carcinoma

  2019cites this paper
• BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance

  2019cites this paper
• Insights into the non-mitotic functions of Aurora kinase A: more than just cell division

  2019cites this paper
• Phosphorylation of the DNA damage mediator Rad 9 by cyclin-dependent kinases ( CDKs ) regulates activation of Checkpoint kinase 1 ( Chk 1 )

  2018cites this paper
• Cyclin B1 stability is increased by interaction with BRCA1, and its overexpression suppresses the progression of BRCA1-associated mammary tumors

  2018cites this paper
• Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1

  2018cites this paper
• The BET inhibitor INCB054329 reduces homologous recombination efficiency and augments PARP inhibitor activity in ovarian cancer.

  2018influential citation
• Elucidating the novel BRCA1 function as a non-genomic metabolic restraint in ER-positive breast cancer cell lines

  2018cites this paper
• Aurora A kinase regulates non-homologous end-joining and poly(ADP-ribose) polymerase function in ovarian carcinoma cells

  2017cites this paper
• Precision genome editing in the CRISPR era.

  2017cites this paper
• Impact of Etoposide on BRCA1 Expression in Various Breast Cancer Cell Lines

  2017cites this paper
• Resolving the Functional Significance of BRCA1 RING Domain Missense Substitutions

  2016cites this paper
• BRE plays an essential role in preventing replicative and DNA damage-induced premature senescence

  2016cites this paper
• A TGFβ–miR-182–BRCA1 axis controls the mammary differentiation hierarchy

  2016cites this paper
• Breast cancer predisposition gene brca1, pathogenic c61g mutation in mice: synthetic viability in DNA repair and tumour development

  2016cites this paper
• Detection of single amino acid mutation in human breast cancer by disordered plasmonic self-similar chain

  2015cites this paper
• TUSC4 functions as a tumor suppressor by regulating BRCA1 stability.

  2015cites this paper
• BRCA1 functions as a novel transcriptional cofactor in HIV-1 infection

  2015cites this paper
• The role of Rak in the regulation of stability and function of BRCA1

  2015cites this paper
• NUSAP1 influences the DNA damage response by controlling BRCA1 protein levels

  2014cites this paper
• Management of Hereditary Ovarian–Breast Cancer

  2014cites this paper
• Opportunities and hurdles in the treatment of BRCA1-related breast cancer

  2014cites this paper
• The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers.

  2014cites this paper
• Novel Approaches to Studying BRCA Variants of Unknown Clinical Significance

  2014cites this paper
• The K898E germline variant in the PP1-binding motif of BRCA1 causes defects in DNA Repair

  2014cites this paper
• LKB1 preserves genome integrity by stimulating BRCA1 expression

  2014cites this paper
• Physiological modulation of endogenous BRCA1 p220 abundance suppresses DNA damage during the cell cycle

  2013cites this paper
• Transgenic expression of BRCA1 disturbs hematopoietic stem and progenitor cells quiescence and function.

  2013cites this paper
• BRCA1-Ku80 Protein Interaction Enhances End-joining Fidelity of Chromosomal Double-strand Breaks in the G1 Phase of the Cell Cycle*

  2013cites this paper
• The budding yeast Rad 9 checkpoint protein is subjected to Mec 1 / Tel 1-dependent hyperphosphorylation and interacts with Rad 53 after DNA damage

  2013cites this paper
• Site-Specific Phosphorylation of the DNA Damage Response Mediator Rad9 by Cyclin-Dependent Kinases Regulates Activation of Checkpoint Kinase 1

  2013cites this paper
• Yin Yang 1 positively regulates BRCA1 and inhibits mammary cancer formation

  2012cites this paper
• Translational Oncogenomics and Human Cancer Interactome Networks: Recent Developments, Complex System Dynamic Approaches and Novel Techniques

  2012cites this paper
• Analysis of Saccharomyces cerevisiae Mec1 and Rad9 functions in the DNA Damage Response

  2012cites this paper
• Deregulation of BRCA1 Leads to Impaired Spatiotemporal Dynamics of γ-H2AX and DNA Damage Responses in Huntington’s Disease

  2012cites this paper
• The BRCA1 Breast Cancer Suppressor: Regulation of Transport, Dynamics, and Function at Multiple Subcellular Locations

  2012cites this paper
• Eukaryotic DNA damage checkpoint activation in response to double-strand breaks

  2012cites this paper
• Clinical Trials in Cancer and Pharmacogenomics: A Critical Evaluation

  2012cites this paper
• The Role of BRCA1 Domains and Motifs in Tumor Suppression

  2011cites this paper
• BRCA1 (breast cancer 1, early onset)

  2011cites this paper
• Translational Oncogenomics and Human Cancer Interactome Networks : Techniques and Complex System Dynamic Approaches

  2011cites this paper
• The Analysis of Bionetwork Dynamics 2. Techniques and Application Examples 2.1. DNA Microarrays 2.2. Oligonucleotide Arrays 2.3. Gene Expression – Microarray Data Analysis 2.4. Protein Microarrays 2.5. Tissue Arrays 2.6. Fluorescence Correlation Spectroscopy and Fluorescence Cross--Correlation Spect

  2011cites this paper
• Influence des hormones stéroïdes et potentiel préventif d'un antiprogestatif, l'ulpristal acétate, dans la tumorigenèse liée à la mutation du gène BRCA1

  2011cites this paper
• Histone methyltransferase EZH2 induces Akt-dependent genomic instability and BRCA1 inhibition in breast cancer.

  2011cites this paper
• Translational Oncogenomics and Human Cancer Interactomics: Advanced Techniques and Complex System Dynamic Approaches

  2011cites this paper
• Tumor and Stem Cell Biology Histone Methyltransferase EZH 2 Induces Akt-Dependent Genomic Instability and BRCA 1 Inhibition in Breast Cancer

  2011cites this paper
• HERC2 is an E3 ligase that targets BRCA1 for degradation.

  2010cites this paper
• Hereditary ovarian cancers: from BRCA mutations to clinical management. A modern appraisal

  2010cites this paper
• AKT regulates BRCA1 stability in response to hormone signaling.

  2010cites this paper
• BRCA1 and EGFR as prognostic biomarkers in triple negative metastatic breast cancer patients treated with cisplatin plus docetaxel

  2010cites this paper
• HERC 2 Is an E 3 Ligase That Targets BRCA 1 for Degradation

  2010cites this paper
• BRCA1 modulates malignant cell behavior, the expression of survivin and chemosensitivity in human breast cancer cells

  2009cites this paper
• The role of BACH1 , BARD1 and TOPBP1 genes in familial breast cancer

  2009cites this paper
• Brca1 is required for embryonic development of the mouse cerebral cortex to normal size by preventing apoptosis of early neural progenitors

  2009cites this paper
• Cell cycle regulation of the BRCA1/acetyl-CoA-carboxylase complex.

  2009cites this paper
• A PP1-binding motif present in BRCA1 plays a role in its DNA repair function

  2008cites this paper
• MYC in breast tumor progression

  2008cites this paper
• Caspase-dependent BRCA1 cleavage facilitates chemotherapy-induced apoptosis

  2008cites this paper
• BRCA1 185delAG mutant protein, BRAt, amplifies caspase-mediated apoptosis and maspin expression in ovarian cells

  2008cites this paper
• BRCA1 is regulated by Chk2 in response to spindle damage.

  2008cites this paper
• MYC in breast tumor

  2008cites this paper
• Expression patterns of the BRCA1 splicing variants in canine normal tissues and mammary gland tumors.

  2007cites this paper
• RAD51 up-regulation bypasses BRCA1 function and is a common feature of BRCA1-deficient breast tumors.

  2007cites this paper
• Activation of BRCA1/BRCA2-Associated Helicase BACH1 Is Required for Timely Progression through S Phase

  2007cites this paper
• BRCA1 dysfunction in sporadic basal-like breast cancer

  2007cites this paper
• Nuclear export of BRCA1 occurs during early S phase and is calcium-dependent.

  2007cites this paper
• Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes.

  2007cites this paper
• Identification and functional characterization of a PP1-binding site in BRCA1.

  2007cites this paper
• Germline mutations of BRCA 1 in two Korean hereditary breast / ovarian cancer families

  2006cites this paper
• Preplaced cell division: a critical mechanism of autoprotection against S-1,2-dichlorovinyl-L-cysteine-induced acute renal failure and death in mice.

  2006cites this paper
• BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution

  2006cites this paper
• BRCA1 phosphorylation: Biological consequences

  2006cites this paper
• BRCA1-associated complexes: new targets to overcome breast cancer radiation resistance

  2006cites this paper
• BRCA1 Interacts with Poly(A)-binding Protein

  2006cites this paper
• Germline mutations of BRCA1 in two Korean hereditary breast/ovarian cancer families.

  2006cites this paper
• BRCA1 Gene Expression in Breast Cancer: A Correlative Study between Real-time RT-PCR and Immunohistochemistry

  2005cites this paper
• Sporadic breast cancer in young women : a microarray investigation

  2005cites this paper
• Hyperphosphorylation of the BARD1 Tumor Suppressor in Mitotic Cells*

  2005cites this paper
• Regulation of BRCA1, BRCA2 and BARD1 intracellular trafficking

  2005influential citation
• The “portrait” of hereditary breast cancer

  2005cites this paper
• One Carbon Metabolism and Methylation in Breast Tumors

  2005cites this paper
• Nuclear Targeting and Cell Cycle Regulatory Function of Human BARD1*

  2005cites this paper
• Progesterone induces BRCA1 mRNA decrease, cell cycle alterations and apoptosis in the MCF7 breast cancer cell line.

  2005cites this paper
• Quantification by affinity perfusion chromatography of phosphorylated BRCAl and BRCA2 proteins from tumor cells after lycopene treatment.

  2005cites this paper
• BRCA1 interacts with dominant negative SWI/SNF enzymes without affecting homologous recombination or radiation‐induced gene activation of p21 or Mdm2

  2004cites this paper
• Familial breast and ovarian cancers

  2004cites this paper